Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Cediranib to enter phase II trial in advanced biliary tract cancers

June 14, 2010

ANR-94 is active in rodent models of Parkinson's disease

June 14, 2010

Trials suggest dasatinib or nilotinib could replace imatinib as first-line CML therapy

June 14, 2010

MRX-4 improves several symptoms of grass pollen allergy

June 14, 2010

Dystrophin-based gene therapy evaluated in Duchenne's muscular dystrophy

June 14, 2010

Blood estradiol identified as putative biomarker for testicular mature teratoma

June 11, 2010

Preclinical data support clinical evaluation of apadenoson in sickle cell anemia

June 11, 2010

Open-label, extension-phase data support long-term use of rotigotine in RLS

June 11, 2010

SF-353 exhibits antidepressant effects in preclinical tests

June 11, 2010

CVX-060 MAb evaluated in solid tumors in first-in-human trial

June 11, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...